Skip to main content
Log in

Acute demyelinating neuropathy associated with rituximab treatment in a patient with relapsing nephrotic syndrome

  • Letter to the editor
  • Published:
CEN Case Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Cravedi P. Rituximab in membranous nephropathy: not all studies are created equal. Nephron. 2017;135:46–50.

    Article  CAS  Google Scholar 

  2. Iancu Ferfoglia R, Guimarães-Costa R, Viala K, et al. Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study. J Peripher Nerv Syst. 2016;21:10–4.

    Article  CAS  Google Scholar 

  3. Stork AC, Notermans NC, Vrancken AF, Cornblath DR, van der Pol WL. Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment. J Peripher Nerv Syst. 2013;18:189–91.

    Article  CAS  Google Scholar 

  4. Terenghi F, Ardolino G, Nobile-Orazio E. Guillain–Barré syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma. J Peripher Nerv Syst. 2007;12:142–3.

    Article  CAS  Google Scholar 

  5. Weiss MD, Becker P. Paradoxical worsening of anti-myelin associated glycoprotein polyneuropathy following rituximab. Muscle Nerve. 2014;49:457–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuliana Galassi.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest exists.

Human and animal rights statement

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

No identifying information about individuals is included in the paper.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Galassi, G., Testa, F., Bianchi, F. et al. Acute demyelinating neuropathy associated with rituximab treatment in a patient with relapsing nephrotic syndrome. CEN Case Rep 6, 215–216 (2017). https://doi.org/10.1007/s13730-017-0264-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-017-0264-3

Navigation